Critical Path Institute® (C-Path) and Boston Medical Center (BMC) published results for six biomarkers that could improve the early and accurate detection of kidney injury, leading to both the ...
A man who was given a life-saving kidney by his wife has told of how he will "never be able to repay her" for donating the ...
One said: "I have street cats, from a rescue. Almost no need for a vet. Okay, as they got older. But, they got old/ getting ...
A New Port Richey father is battling kidney disease as he searches for a donor. NEW PORT RICHEY, Fla. - March marks national kidney month; a time to raise awareness about kidney diseases, like ...
The National Kidney Foundation says about 500,000 people in the U.S. are battling polycystic kidney disease. Among them: ...
Investing.com -- Shares of Regulus Therapeutics (NASDAQ: RGLS) soared 23.3% today following the announcement of successful results from its Phase 1b multiple ascending dose (MAD) clinical trial of ...
Regulus Therapeutics (RGLS) stock soars after positive Phase 1b trial data for the company's lead asset, farabursen against a ...
Regulus Therapeutics' Phase 1b study shows farabursen 300 mg slowed kidney volume growth in ADPKD patients with a favorable ...
Scientists at Nanyang Technological University, Singapore (NTU Singapore), have made a crucial breakthrough by successfully ...
The following is a summary of “Long-term effect of tolvaptan treatment on kidney function and volume in patients with ADPKD,” ...